3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Lymphocytic, Chronic, B-Cell
19
Lymphoma, Mantle-Cell
9
Lymphoma, Non-Hodgkin
4
Multiple Myeloma
3
Lymphoma, Large B-Cell, Diffuse
3
Waldenstrom Macroglobulinemia
2
Recurrence
2
Pancreatic Neoplasms
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma
2
Squamous Cell Carcinoma of Head and Neck
1
Pyloric Stenosis, Hypertrophic
1
Ovarian Neoplasms
1
Neoplasm, Residual
1
Lymphoma, B-Cell
1
Leukemia, Prolymphocytic
1
Leukemia, Hairy Cell
1
Leukemia
1
Immunoproliferative Disorders
1
Immune System Diseases
1
Hodgkin Disease
1
Glioblastoma
1
DLBCL
1
Chromosome 17 deletion
1
Carcinoma, Transitional Cell
1
Carcinoma, Non-Small-Cell Lung
1
Burkitt Lymphoma
1
Anemia, Hemolytic, Autoimmune
1
Advanced Haematological Malignancies
1
Interventions
ofatumumab
10
Cyclophosphamide
6
fludarabine
5
ibrutinib
4
fludarabine phosphate
4
Bortezomib
3
Tablets
2
Chlorambucil
2
tirabrutinib
1
pegaspargase
1
nelarabine
1
immunotoxin HA22
1
bempegaldesleukin
1
Whole-Body Irradiation
1
Vincristine
1
Panobinostat
1
Observation
1
Nivolumab
1
Mitoxantrone
1
Methotrexate
1
Mesna
1
Mercaptopurine
1
Magnetic Resonance Imaging
1
MLN 8237
1
Lenalidomide
1
KW-2478
1
Hsp90 inhibitor KU757
1
Etoposide
1
Electrocardiography
1
Echocardiography
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, B-Cell
×
acalabrutinib
×
Clear all
No trials found.